The poultry vaccines market is growing as demand for poultry meat and eggs increases worldwide. The market was valued at USD 2.05 billion in 2024 and is projected to reach USD 3.97 billion by 2035, expanding at a CAGR of 6.18%.

Vaccination is essential for protecting poultry flocks from diseases that can affect animal health, production output, food supply, and farm profitability. Major disease targets include Newcastle disease, infectious bursal disease, avian influenza, and Marek’s disease.

Live attenuated vaccines are the largest vaccine type because they can provide strong immune responses and are widely used in poultry health programs. Inactivated vaccines are the fastest-growing category due to their safety profile and increasing demand for more controlled disease-management strategies.

Broilers are the largest species segment because of high global poultry-meat production. Layers are a fast-growing segment as egg consumption rises and producers seek to protect flock health and productivity.

Poultry producers increasingly view vaccines as part of broader biosecurity systems. These systems may include farm hygiene, controlled entry, disease surveillance, proper nutrition, sanitation, and regular veterinary support.

Read more: Poultry Vaccines Market

FAQs

Q1. What diseases do poultry vaccines target?
Major targets include Newcastle disease, avian influenza, infectious bursal disease, and Marek’s disease.

Q2. Which poultry segment drives the largest vaccine demand?
Broilers lead due to the scale of global poultry-meat production.

Tags: poultry vaccines, animal health, broiler vaccines, avian influenza, poultry disease prevention